{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:53:45Z","timestamp":1761166425434,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-14-0294","APVV-15-0111","APVV-17-0239"],"award-info":[{"award-number":["APVV-14-0294","APVV-15-0111","APVV-17-0239"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010783","name":"Slovensk\u00e1 Akad\u00e9mia Vied","doi-asserted-by":"publisher","award":["VEGA 1\/0228\/17"],"award-info":[{"award-number":["VEGA 1\/0228\/17"]}],"id":[{"id":"10.13039\/100010783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jmgm.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T10:50:15Z","timestamp":1534416615000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM\/MM calculations"],"prefix":"10.1016","volume":"85","author":[{"given":"Jakub","family":"Kollar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-5860","authenticated-orcid":false,"given":"Vladimir","family":"Frecer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2018.08.008_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.jmgm.2018.08.008_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbagrm.2010.05.008","article-title":"Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions","volume":"1799","author":"Marks","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmgm.2018.08.008_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2174\/1381612820666141110164604","article-title":"Selective inhibitors of zinc-dependent histone deacetylases. Therapeutic targets relevant to cancer","volume":"21","author":"Kollar","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.jmgm.2018.08.008_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2018.08.008_bib5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4155\/fmc-2016-0117","article-title":"Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases","volume":"8","author":"Chakrabarti","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib6","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases","volume":"1\u201315","author":"Hull","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jmgm.2018.08.008_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.jmgm.2018.08.008_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmgm.2018.08.008_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","article-title":"Class II histone deacetylases: versatile regulators","volume":"19","author":"Verdin","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.jmgm.2018.08.008_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.sbi.2011.08.004","article-title":"Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes","volume":"21","author":"Lombardi","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib11","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2018.08.008_bib12","doi-asserted-by":"crossref","first-page":"26694","DOI":"10.1074\/jbc.M803514200","article-title":"Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain","volume":"283","author":"Bottomley","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.embor.7401047","article-title":"Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex","volume":"8","author":"Vannini","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jmgm.2018.08.008_bib14","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/jm4011884","article-title":"Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease","volume":"56","author":"B\u00fcrli","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o01-116","article-title":"The emerging role of class II histone deacetylases","volume":"79","author":"Fischle","year":"2001","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1582-4934.2011.01321.x","article-title":"Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis","volume":"15","author":"Clocchiatti","year":"2011","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.jmgm.2018.08.008_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/o01-032","article-title":"Class II histone deacetylases: structure, function, and regulation","volume":"79","author":"Bertos","year":"2001","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib18","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","article-title":"Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha","volume":"66","author":"Qian","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.jmgm.2018.08.008_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2018.08.008_bib20","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.08-108548","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"Granger","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.jmgm.2018.08.008_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","volume":"71","author":"Hancock","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jmgm.2018.08.008_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2018.08.008_bib23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmgm.2018.08.008_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not Be the best histone deacetylase inhibitors-what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2018.08.008_bib26","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio.1223","article-title":"Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group","volume":"9","author":"Lobera","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03417-1","article-title":"Novel class IIa-selective histone deacetylase inhibitors discovered using an in silico virtual screening approach","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2018.08.008_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00018-014-1727-8","article-title":"Selective class IIa HDAC inhibitors: myth or reality","volume":"72","author":"Di Giorgio","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmgm.2018.08.008_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsmedchemlett.5b00302","article-title":"Potent, selective, and CNS-penetrant tetrasubstituted cyclopropane class IIa histone deacetylase (HDAC) inhibitors","volume":"7","author":"Luckhurst","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2018.08.008_bib31","doi-asserted-by":"crossref","first-page":"e44498","DOI":"10.1371\/journal.pone.0044498","article-title":"Oral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in\u00a0vivo","volume":"7","author":"Beconi","year":"2012","journal-title":"PLoS One"},{"year":"2011","series-title":"Fluorinated HDAC Inhibitors and Uses Thereof","author":"Bradner","key":"10.1016\/j.jmgm.2018.08.008_bib32"},{"key":"10.1016\/j.jmgm.2018.08.008_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/minf.201400034","article-title":"Future de novo drug design","volume":"33","author":"Schneider","year":"2014","journal-title":"Mol Inform"},{"key":"10.1016\/j.jmgm.2018.08.008_bib35","series-title":"RSC Drug Discov Ser No 23","first-page":"372","article-title":"Physico-chemical and computational approaches to drug discovery","author":"Seneci","year":"2012"},{"key":"10.1016\/j.jmgm.2018.08.008_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/cr9603744","article-title":"The Cation\u2212\u03c0 interaction","volume":"97","author":"Ma","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cphc.200500039","article-title":"Solute-solvent charge transfer in aqueous solution","volume":"6","author":"Dal Peraro","year":"2005","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.jmgm.2018.08.008_bib38","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm048973n","article-title":"Large-scale validation of a quantum mechanics based scoring function: predicting the binding affinity and the binding mode of a diverse set of Protein\u2212ligand complexes","volume":"48","author":"Raha","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib39","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/cr050579p","article-title":"Target-related applications of first principles quantum chemical methods in drug design","volume":"106","author":"Cavalli","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/jcc.20686","article-title":"Change in a Protein's electronic structure induced by an explicit solvent: an ab initio fragment molecular orbital study of ubiquitin","volume":"28","author":"Komeiji","year":"2007","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1573409911309010003","article-title":"First-principles modeling of biological systems and structure-based drug-design","volume":"9","author":"Sgrignani","year":"2013","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jmgm.2018.08.008_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17460441.2015.1076389","article-title":"Simulation with quantum mechanics\/molecular mechanics for drug discovery","volume":"10","author":"Barbault","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2018.08.008_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/156802610790232297","article-title":"QM\/MM approaches in medicinal chemistry research","volume":"10","author":"Menikarachchi","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.physchem.55.091602.094410","article-title":"Ab initio quantum chemical and mixed quantum mechanics\/molecular mechanics (QM\/MM) methods for studying enzymatic catalysis","volume":"56","author":"Friesner","year":"2005","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib45","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/anie.200802019","article-title":"QM\/MM methods for biomolecular systems","volume":"48","author":"Senn","year":"2009","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jmgm.2018.08.008_bib46","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1021\/acs.jpcb.6b08581","article-title":"Uniform free-energy profiles of the P\u2013O bond formation and cleavage reactions catalyzed by DNA polymerases \u03b2 and \u03bb","volume":"120","author":"Klva\u0148a","year":"2016","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2018.08.008_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-017-3537-z","article-title":"How accurate is the description of ligand\u2013protein interactions by a hybrid QM\/MM approach?","volume":"24","author":"Kollar","year":"2018","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.jmgm.2018.08.008_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.08.008_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2018.08.008_bib50","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1021\/jo070739s","article-title":"Zinc binding in HDAC inhibitors: a DFT study","volume":"72","author":"Wang","year":"2007","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib51","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1039\/B304707E","article-title":"Ab initio study of the binding of Trichostatin A (TSA) in the active site of Histone Deacetylase like Protein (HDLP)","volume":"1","author":"Vanommeslaeghe","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib52","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.bmc.2005.04.001","article-title":"Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase","volume":"13","author":"Vanommeslaeghe","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C4MD00471J","article-title":"Application of QM\/MM and QM methods to investigate histone deacetylase 8","volume":"6","author":"Gleeson","year":"2015","journal-title":"Med Chem Commun"},{"volume":"vols. 14\u20132","year":"2014","author":"MacroModel, version 10.4","key":"10.1016\/j.jmgm.2018.08.008_bib54"},{"key":"10.1016\/j.jmgm.2018.08.008_bib55","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2018.08.008_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J.\u00a0Comput. Chem."},{"volume":"vols. 14\u20132","year":"2014","author":"Impact, version 6.2","key":"10.1016\/j.jmgm.2018.08.008_bib57"},{"key":"10.1016\/j.jmgm.2018.08.008_bib58","doi-asserted-by":"crossref","first-page":"A1133","DOI":"10.1103\/PhysRev.140.A1133","article-title":"Self-consistent equations including exchange and correlation effects","volume":"140","author":"Kohn","year":"1965","journal-title":"Phys. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib59","doi-asserted-by":"crossref","first-page":"B864","DOI":"10.1103\/PhysRev.136.B864","article-title":"Inhomogeneous electron gas","volume":"136","author":"Hohenberg","year":"1964","journal-title":"Phys. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib60","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","article-title":"Density-functional exchange-energy approximation with correct asymptotic behavior","volume":"38","author":"Becke","year":"1988","journal-title":"Phys. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib61","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. Iii. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.08.008_bib62","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/j100096a001","article-title":"Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields","volume":"98","author":"Stephens","year":"1994","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1063\/1.1674902","article-title":"Self-consistent molecular-orbital methods. IX. An extended Gaussian-Type basis for molecular-orbital studies of organic molecules","volume":"54","author":"Ditchfield","year":"1971","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.08.008_bib64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-2614(00)00289-X","article-title":"Frozen orbital QM\/MM methods for density functional theory","volume":"321","author":"Murphy","year":"2000","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jmgm.2018.08.008_bib65","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/(SICI)1096-987X(19991115)20:14<1468::AID-JCC2>3.0.CO;2-0","article-title":"Mixed ab initio QM\/MM modeling using frozen orbitals and tests with alanine dipeptide and tetrapeptide","volume":"20","author":"Philipp","year":"1999","journal-title":"J.\u00a0Comput. Chem."},{"volume":"vols. 14\u20132","year":"2014","author":"QSite, version 6.3","key":"10.1016\/j.jmgm.2018.08.008_bib66"},{"key":"10.1016\/j.jmgm.2018.08.008_bib67","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: a high-performance quantum chemistry software program with strengths in life and materials Sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quant. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib68","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.jmgm.2018.08.008_bib69","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/0006-2952(75)90050-7","article-title":"Tight-binding inhibitors-I. Kinetic behavior","volume":"24","author":"Cha","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib70","first-page":"211","article-title":"Rational resign of inhibitors for drug-resistant HIV-1 aspartic protease mutants","volume":"15","author":"Frecer","year":"1998","journal-title":"Drug Des. Discov."},{"key":"10.1016\/j.jmgm.2018.08.008_bib71","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/1521-3935(200207)203:10\/11<1650::AID-MACP1650>3.0.CO;2-E","article-title":"Interactions of ligands with macromolecules: rational design of specific inhibitors of aspartic protease of HIV-1","volume":"203","author":"Frecer","year":"2002","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.08.008_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jmgm.2008.06.006","article-title":"Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing \u2013Phe\u03a8Pro\u2013 core and displaying favourable ADME-related properties","volume":"27","author":"Frecer","year":"2008","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2018.08.008_bib73","doi-asserted-by":"crossref","first-page":"12782","DOI":"10.1021\/jp056623m","article-title":"Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method","volume":"110","author":"Bren","year":"2006","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2018.08.008_bib74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00214-007-0264-z","article-title":"Do all pieces make a whole? Thiele cumulants and the free energy decomposition","volume":"117","author":"Bren","year":"2007","journal-title":"Theor Chem Acc"},{"volume":"vols. 14\u20132","year":"2014","author":"CombiGlide, version 3.3","key":"10.1016\/j.jmgm.2018.08.008_bib75"},{"key":"10.1016\/j.jmgm.2018.08.008_bib76","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib77","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib78","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425255.2.2.325","article-title":"Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery","volume":"2","author":"Segall","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jmgm.2018.08.008_bib79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/156802605774297038","article-title":"Strategy of utilizing in\u00a0vitro and in\u00a0vivo ADME tools for lead optimization and drug candidate selection","volume":"5","author":"Balani","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"volume":"vols. 14\u20132","year":"2014","author":"QikProp, version 3.9","key":"10.1016\/j.jmgm.2018.08.008_bib80"},{"key":"10.1016\/j.jmgm.2018.08.008_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","article-title":"Prediction of drug solubility from structure","volume":"54","author":"Jorgensen","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jmgm.2018.08.008_bib82","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","article-title":"Prediction of drug solubility from Monte Carlo simulations","volume":"10","author":"Jorgensen","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2018.08.008_bib83","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2018.08.008_bib84","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/jp807277r","article-title":"Evaluating boundary dependent errors in QM\/MM simulations","volume":"113","author":"Solt","year":"2009","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2018.08.008_bib85","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1021\/acs.jpcb.6b07203","article-title":"Exploring the dependence of QM\/MM calculations of enzyme catalysis on the size of the QM region","volume":"120","author":"Jindal","year":"2016","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2018.08.008_bib86","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1021\/jp902876n","article-title":"A\u00a0convergence study of QM\/MM isomerization energies with the selected size of the QM region for peptidic systems","volume":"113","author":"Sumowski","year":"2009","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.jmgm.2018.08.008_bib87","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/ct100530r","article-title":"On the convergence of QM\/MM energies","volume":"7","author":"Hu","year":"2011","journal-title":"J.\u00a0Chem. Theor. Comput."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318303802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318303802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:59:14Z","timestamp":1761080354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326318303802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":87,"alternative-id":["S1093326318303802"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.08.008","relation":{},"ISSN":["1093-3263"],"issn-type":[{"type":"print","value":"1093-3263"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM\/MM calculations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}